Please assess the completion status of the following clinical trial:

Trial Title: Trial Comparing Patching With Active Vision Therapy to Patching With Control Vision Therapy as Treatment for Amblyopia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age 7 to \<13 years~* Amblyopia associated with anisometropia, strabismus (comitant or incomitant), or both at the time of the eligibility examination~* Visual acuity in the amblyopic eye between 49 and 71 letters inclusive (20/40 to 20/100 inclusive) on the eETDRS~* Visual acuity in the sound eye of 79 or more letters on the eETDRS (20/25 or better)~* Inter-eye acuity difference of 15 or more letters (3 or more logMAR lines)~* At least 800 seconds of arc on the Randot Preschool Stereoacuity Test~* Previous or current amblyopia treatment with spectacles or contact lenses, patching or atropine is permitted.~* No myopia more than -6.00 D spherical equivalent in the amblyopic eye~* Single vision spectacles, if needed, worn for at least 16 weeks or until visual acuity documented to be stable~* The child has access to a computer on a daily basis (to use the home vision therapy software)~Exclusion Criteria:~* Previous vision therapy or orthoptics~* Known skin reactions to patch or bandage adhesives~* Prior intraocular or refractive surgery~* Bifocals~* Constant strabismus at near at the eligibility examination~* A family member is (or has been) enrolled in this study

- Gender: ALL
- Minimum Age: 7 Years
- Maximum Age: 12 Years
- Healthy Volunteers: f

Study Arms:
- Active (Type: ACTIVE_COMPARATOR): 2 hours of daily patching combined with 1 hour daily of near activities (that includes 30 minutes of at-home active vision therapy) and weekly in-office active vision therapy
- Control (Type: SHAM_COMPARATOR): 2 hours of daily patching combined with 1 hour of daily near activities (that includes 30 minutes of at-home control vision therapy) and weekly in-office control vision therapy

Based on this trial design, predict the completion outcome and termination type (if applicable).